Back to results
US 6,284,891 B1Granted
Method for preparing camptothecin derivatives
AssigneeGilead Sciences, Inc.
InventorsFrancis Gerard Fang, Shiping Xie
Life of this patent
Estimating the term…
Abstract
The present invention relates to a process for preparing camptothecin and camptothecin analogs of Formula (I) from compounds of Formula (II) and to novel intermediates useful in their preparation, wherein R1 to R6 represent various substituents.
Claims4
A compound of Formulas (IV) or (VI):
- wherein:
- X is halo;
- R1 and R2, which may be the same or different, are independently selected from hydrogen, lower alkyl, (C3-7) cycloalkyl, (C3-7)cycloalkyl lower alkyl, lower alkenyl, hydroxy lower alkyl, or alkoxy alkyl, or (—CH2NR7R8), wherein:
- i) R7 and R8, which may be the same or different, are independently selected from hydrogen, lower alkyl, (C3-7) cycloalkyl, (C3-7) cycloalkyl lower alkyl, lower alkenyl, hydroxy lower alkyl, or lower alkoxy lower alkyl;
- or
- ii) R7 represents hydrogen, lower alkyl, (C3-7)cycloalkyl, (C3-7) cycloalkyl lower alkyl, lower alkenyl, hydroxy lower alkyl, or lower alkoxy lower alkyl, and R8 represents —COR9,
- wherein:
- R9 represents hydrogen, lower alkyl, perhalo-lower alkyl, (C3-7)cycloalkyl, (C3-7) cycloalkyl lower alkyl, lower alkenyl, hydroxy lower alkyl, lower alkoxy, lower alkoxy lower alkyl;
- or
- iii) R7 represents hydrogen or lower alkyl;
- and R8 represents diphenyl-methyl or —(CH2)tAr
- wherein:
- t is 0 to 5 and Ar represents phenyl, furyl, pyridyl, N-methylpyrrolyl, imidazolyl optionally substituted with one or more substituents selected from hydroxy, methyl, halogen, and amino;
- or
- iv) R7 and R8 taken together with the linking nitrogen form a saturated 3 to 7 atom heterocyclic group of formula (IA)
- wherein:
- Y represents O, S, SO, SO2, CH2 or NR10,
- wherein:
- R10 represents hydrogen, lower alkyl, perhalo lower alkyl, aryl, aryl substituted with one or more substituents selected from lower alkyl, lower alkoxy, halogen, nitro, amino, lower alkyl amino, perhalo-lower alkyl, hydroxy lower alkyl, lower alkoxy lower alkyl groups or —COR11,
- wherein:
- R11 represents hydrogen, lower alkyl, perhalo-lower alkyl, lower alkoxy, aryl, aryl substituted with one or more substituents selected from lower alkyl, perhalo-lower alkyl, hydroxy lower alkyl, lower alkoxy lower alkyl groups;
- and
- R3 and R4 are independently selected from hydrogen, lower alkyl, (C3-7)cycloalkyl, (C3-7)cycloalkyl lower alkyl, lower alkenyl, hydroxy lower alkyl, or alkoxy alkyl;
- or
- R3 and R4 taken together form a saturated 5 to 6 atom heterocyclic group of formula (IB)
- wherein,
- n represents the integer 1 or 2;
- and
- R5 represents hydrogen or lower alkyl, and
- R6 represents hydrogen or lower alkyl, or
- pharmaceutically acceptable salts thereof.
28 more elements
A compound selected from the group consisting of:
- 4-Ethyl-1H-pyrano[3,4-c]pyridin-8-one;
- or
- 4-Ethyl-7-[7-iodo-9-[(4-methyl-piperazinyl)methyl]-2,3-dihydro-[1,4]dioxino[2,3-g]quinolin-8-ylmethyl]-1H-pyrano[3,4-c]pyridin-8-one.
Dependencies are inferred from the claim text.